Abstract:Anticancer drugs inhibit DNA replication by intercalating between DNA base pairs, forming covalent bonds with nucleotide bases, or binding to the DNA groove. To develop safer drugs, novel molecular structures with alternative binding mechanisms are essential. Stable boron hydrides offer a promising alternative for cancer therapy, opening up additional options like boron neutron capture therapy based on 10B and thermal neutron beams or proton boron fusion therapy using 11B and proton beams. These therapies are more efficient when the boron compound is ideally located inside cancer cells, particularly in the nucleus. Current cancer treatments often utilize small, polycyclic, aromatic, planar molecules that intercalate between ds-DNA base pairs, requiring only a spacing of approximately 0.34 nm. In this paper, we demonstrate another type of intercalation. Notably, [3,3'-Fe(1,2-C2B9H11)2]-, ([o-FESAN]-), a compact 3D molecule measuring 1.1 nm × 0.6 nm, can as well intercalate by strong non-bonding interactions preferentially with guanine. Unlike known intercalators, which are positive or neutral, [o-FESAN]- is a negative species and when an [o-FESAN]- molecule approaches the negatively charged DNA phosphate chain an anion-anion interaction consistently anti-electrostatic via Ccluster-H⋯O-P bonds occurs. Then, when more molecules approach, an elongated outstandingly self-assembled structure of [o-FESAN]--[o-FESAN]- forms moving anions towards the interthread region to interact with base pairs and form aggregates of four [o-FESAN]- anions per base pair. These aggregates, in this environment, are generated by Ccluster-H⋯O-C, N-H⋯H-B and Ccluster-H⋯H-B interactions. The ferrabis(dicarbollide) boron-rich small molecules not only effectively penetrate the nucleus but also intercalate with ds-DNA, making them promising for cancer treatment. This amphiphilic anionic molecule, used as a carrier-free drug, can enhance radiotherapy in a multimodal perspective, providing healthcare professionals with improved tools for cancer treatment. This work demonstrates these findings with a plethora of techniques.

Amino acid-functionalized borospherenes as drug delivery systems.

A DFT approach towards therapeutic potential of Novel borospherene as targeted drug delivery system for isoniazid drug

Anticancer drugs delivery and adsorption computations in pure and Stone–Wales defect armchair graphene nanoribbons

Heterofullerene MC59 (M = B, Si, Al) as Potential Carriers for Hydroxyurea Drug Delivery

The first principal study of decorated hexagonal boron nitride nanosheets with Ni and Pd atoms as drug carrier

On the potential of all-boron fullerene B40 as a carrier for anti-cancer drug nitrosourea

Assessment of the drug delivery potential of graphene, boron nitride and their in-plane doped structures for hydroxyurea anti-cancer drug via DFT study

[Basic Organic and Inorganic Chemistry of Boron Clusters and Its Application to Drug Discovery].

Synthesis and characterization of a novel functionalized azanonaborane cluster for boron neutron capture therapy

Hyaluronic acid-decorated carborane-TAT conjugation nanomicelles: A potential boron agent with enhanced selectivity of tumor cellular uptake

Compelling DNA intercalation through 'anion-anion' anti-coulombic interactions: boron cluster self-vehicles as promising anticancer agents

Hexagonal boron nitride nanosheet as novel drug delivery system for anticancer drugs: Insights from DFT calculations and molecular dynamics simulations

Highly Water-Soluble, Porous, and Biocompatible Boron Nitrides for Anticancer Drug Delivery.

Mortality among augmentation mammoplasty patients.

Towards the Application of Purely Inorganic Icosahedral Boron Clusters in Emerging Nanomedicine

Comparative prediction of binding affinity of Hydroxyurea anti-cancer to boron nitride and carbon nanotubes as smart targeted drug delivery vehicles

Aryl bromide/triflate selectivities reveal mechanistic divergence in palladium-catalysed couplings; the Suzuki-Miyaura anomaly.

Molecular Engineering of AIE-active Boron Clustoluminogens for Enhanced Boron Neutron Capture Therapy.

Enzyme-instructed supramolecular assemblies promote intracellular boron accumulation for boron neutron capture therapy

Structural characterization of cationic liposomes loaded with sugar-based carboranes

Fluorescent Sensing for Boronic Acid Derivatives: Design, Synthesis, Mechanism, Application and Perspective in Boron Neutron Capture Therapy (BNCT)